Search

Repligen Corp

Открыт

СекторЗдравоохранение

178.17 3.1

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

172.07

Макс.

181.35

Ключевые показатели

By Trading Economics

Доход

-3.3M

5M

Продажи

9.9M

204M

P/E

Средняя по отрасли

243.473

50.373

Прибыль на акцию

0.53

Рентабельность продаж

2.453

Сотрудники

2,000

EBITDA

14M

46M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+21.59% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4B

11B

Предыдущая цена открытия

175.07

Предыдущая цена закрытия

178.17

Repligen Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

2 нояб. 2026 г., 21:09 UTC

Correlated Moves

Repligen Corporation shares are declining amid a broader market downturn, trading well below their 20-day moving average following an early spike that quickly reversed.

30 окт. 2026 г., 20:03 UTC

News

Repligen Corporation announced a $1 billion issuance of Convertible Senior Notes due 2031, with plans to repurchase shares using $120 million of the proceeds.

29 окт. 2026 г., 20:02 UTC

Repligen Corporation shares are advancing, remaining significantly above their 20-day moving average and near the upper end of their one-month range.

28 окт. 2026 г., 23:03 UTC

Repligen Corporation is advancing in after-market trading, showing strong performance since Wednesday's close and trading near the upper end of its one-month range.

27 окт. 2026 г., 20:01 UTC

News

Repligen Corporation reported Q3 adjusted EPS of $0.53 and revenue of $209.31 million, while narrowing FY 2026 EPS guidance amid a $38.4 million loss.

26 окт. 2026 г., 20:07 UTC

Correlated Moves

Repligen Corp shares are higher, following an upward trend in Charles River Laboratories, which is benefiting from positive developments in its product pipeline.

23 окт. 2026 г., 19:16 UTC

Repligen Corp shares are declining, having pulled back from earlier gains and currently trading significantly below their 20-day moving average.

22 окт. 2026 г., 20:07 UTC

Correlated Moves

Repligen Corp shares are declining amid a broader downturn in the Life Sciences Tools & Services sector, pulling back from earlier session highs.

21 окт. 2026 г., 20:07 UTC

Correlated Moves

Repligen Corp's shares are advancing, regaining momentum after an earlier pullback, alongside a broader market rise and notable trading activity in Charles River Laboratories.

20 окт. 2026 г., 20:08 UTC

Repligen Corp shares are advancing, continuing a trend higher since Monday's close, despite earlier pulling back from a session high.

19 окт. 2026 г., 19:36 UTC

News

Canaccord Genuity raises Repligen Corp's price target to $180.00 from $145.00 while maintaining a Hold rating, reflecting a positive reassessment of the company's value.

16 окт. 2026 г., 22:01 UTC

Repligen Corp is trading lower in after-market hours, following a notable decline since Friday's close amid unusual volatility and positioning near its one-month range low.

15 окт. 2026 г., 20:07 UTC

Repligen Corp shares advanced, reaching a peak before the session's conclusion.

14 окт. 2026 г., 20:07 UTC

Repligen Corp shares are advancing, benefiting from broader market gains, despite pulling back from earlier session highs. The stock is higher since Tuesday's close.

13 окт. 2026 г., 20:07 UTC

News

Repligen Corp shares are advancing as the company prepares to report its third-quarter 2026 financial results on October 27, 2026.

12 окт. 2026 г., 21:03 UTC

Repligen Corp shares advanced during after-market hours on Monday, moving from a low return to a high return.

9 окт. 2026 г., 20:01 UTC

Repligen Corp shares are sharply higher, continuing an upward trajectory since Thursday's close, supported by positive movement in the broader life sciences sector.

8 окт. 2026 г., 20:07 UTC

Repligen Corp shares fell sharply, continuing a downward trend with three consecutive sessions down, despite a brief recovery earlier in the session.

7 окт. 2026 г., 20:01 UTC

News

Repligen Corp. finalized its $1.5 billion acquisition of BioLife Solutions, but shares fell sharply amid ongoing declines following a prior session drop.

6 окт. 2026 г., 21:01 UTC

Repligen Corp's shares traded modestly higher in after-market hours, marking a peak since Tuesday's close despite remaining below the 20-day moving average.

5 окт. 2026 г., 22:15 UTC

News

Repligen Corp plans to acquire BioLife Solutions, contributing to a modest after-market hours gain as the stock remains above its 20-day moving average.

2 окт. 2026 г., 20:07 UTC

Repligen Corp's shares are advancing, reflecting a broader market trend, maintaining strong performance above the 20-day moving average amid notable intraday volatility.

1 окт. 2026 г., 20:02 UTC

Repligen Corp shares fell sharply, breaking a trend of higher daily closes and diverging from recent upward momentum.

30 сент. 2026 г., 21:01 UTC

Repligen Corp is advancing in after-market trading, reflecting broader market gains amid revised Q2 GDP growth and stronger consumer spending.

29 сент. 2026 г., 23:25 UTC

Repligen Corp has seen a modest decline in after-market trading, retracing from earlier gains and reflecting unusual volatility compared to Tuesday's close.

28 сент. 2026 г., 20:07 UTC

Repligen Corp shares are higher today, maintaining an upward trajectory since Friday's close, supported by strong performance in the life sciences sector.

25 сент. 2026 г., 21:01 UTC

Repligen Corp's shares advanced modestly higher during after-market hours, reflecting strong performance and favorable conditions above their 20-day moving average.

24 сент. 2026 г., 22:05 UTC

Repligen Corp's shares advanced modestly higher in after-market trading, currently 9.33% above its 20-day moving average and near the upper end of its one-month range.

23 сент. 2026 г., 23:46 UTC

Repligen Corp's stock declined in after-market trading, hitting its lowest point of the day after Wednesday's close, despite remaining above its 20-day moving average.

22 сент. 2026 г., 20:13 UTC

Repligen Corp's shares advanced modestly in after-market trading, maintaining strength and staying significantly above its 20-day moving average.

Сравнение c конкурентами

Изменение цены

Repligen Corp Прогноз

Целевая цена

By TipRanks

21.59% рост

Прогноз на 12 месяцев

Средняя 210.286 USD  21.59%

Максимум 235 USD

Минимум 180 USD

Основано на мнении 8 аналитиков Wall Street, спрогнозировавших целевые цены для Repligen Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

8 ratings

7

Покупка

1

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat